Shares of oilfield services company Flowco jumped in its market debut Thursday, opening to trade 21% above its IPO price.
Latest IPOs and Direct Listings:
Floco (FLOC) opened on January 16 at $29.00. The provider of production optimization, artificial lift and methane reduction solutions for the oil and natural gas industry has priced its initial public offering of 17.8 million shares of its Class A common stock at a public offering price of $24.00 per share.
Picosella (PCLA) opened on January 16 at $4. The Tokyo-based enterprise wireless networking solutions provider has priced its initial public offering of 1.75 million American depositary shares at a public offering price of $4.00 per ADS. Each ADS represents one common share of company stock. The transaction size was reduced to 1.75 million shares of common stock from 2 million shares of common stock and priced at the lower end of the $4.00-$6.00 range.
Hong Kong Pharma(HKPD) opened on January 15 at $3.50. The cross-border e-commerce supply chain services provider for over-the-counter pharmaceuticals in Hong Kong has priced its initial public offering of an aggregate of 1,403,685 ordinary shares at a public offering price of US$4.00 per share, of which 1 million shares are being offered by Hong Kong Pharma and 403,685 shares are being offered by shareholders. Sellers in the company.
Uni Fuels(UFG) opened on January 14 at $4.59. The company priced 2.1 million shares at a public offering price of $4.00 per share. Uni-Fuels is a marine fuel solutions provider for shipping companies headquartered in Singapore.
Recent SPAC IPO:
Acquisition of the fourth plum (BLMK)open On June 15 at $10.04. The blank check company priced its initial public offering of 15 million units at $10.00 per unit.
Purchase the tape (ribs)open On June 15 at $10.02. The blank check company, listed in the Cayman Islands as an exempt company, priced its initial public offering of 5 million units at an offering price of $10.00 per unit, with each unit consisting of one Class A common share and one right to acquire one-seventh of the shares. One Class A common share upon completion of the initial business combination.
Odyssey Treatments It has filed with the Securities and Exchange Commission an application for an initial public offering of shares of common stock. The company has applied to list its common shares on the Nasdaq Capital Market under the trading symbol “ODTX”. A prospectus filed with the SEC states, “Odyssey is a clinical-stage biopharmaceutical company led by a team and board of drug researchers who seek to transform the standard of care for patients with autoimmune and inflammatory diseases…Our most advanced programs include OD-07656, a small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, for which we intend to initiate a Phase 2a monotherapy trial for ulcerative colitis, or UC, in the first quarter of 2025 and a combined Phase 2a trial with vedolizumab in the first half of 2026, and two preclinical programs: a small-molecule scaffold inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, a therapeutic agonist protein It targets tumor necrosis factor receptor 2, or TNFR2, built of heavy chain variable domains Jamlid, or VHH.
CLPS (CLPS announced that its majority-owned subsidiary, JAJI Global, has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission in connection with the proposed initial public offering of JAJI common stock. Following the offering, CLPS expects to own a significant voting interest in JAJI along with a corresponding economic interest in its subsidiaries. The number of shares to be offered and the price range for the offering have not yet been determined. JAJI intends to list its common stock on the Nasdaq Capital Market. According to the F-1, JAJI currently has a total capital stock of 10 million shares, of which CLPS owns 60%. The funds raised from this IPO will be used primarily for product development, mergers and acquisitions, global expansion and corporate operations to drive JAJI’s sustainable growth.
Infinity Natural Resources It has filed for an initial public offering of its Class A common stock. The Company intends to list its Class A common stock on the New York Stock Exchange under the symbol “INR.” Infinity Natural Resources is an independent exploration and production company “Dedicated to Appalachia.”
Basel Medical Group It has filed for an initial public offering on the Nasdaq under the symbol “BMGL.” Cathay Securities is acting as the guarantor in the deal. Basel is a healthcare provider across Singapore and Southeast Asia.
Shipbob He chose JP Morgan (JPM) to lead its planned listing include Bloomberg’s Amy Orr, Gillian Tan and Ryan Gould a reportciting people familiar with the situation. The Chicago-based e-commerce fulfillment provider also selected Citigorup (C) As part of a union, the authors say. The authors note that an IPO could happen later this year and could value the company at $4 billion.
“Opening Day” is a recurring story series from The Fly about the latest IPOs, their performance and upcoming IPOs.
First published on The fly – The ultimate source for breaking financial news that moves the market in real time. Try now >>
